Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 5,142 shares at $8.06 ($41K) on 2024-12-06, disclosed to the SEC on 2024-12-10.
Seasonal sale ($41k) by President and CEO — this insider has traded ENTA in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |
| ENTA | SELL | 2022-12-16 | $2.3M | — | Filing → |